检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

25 A phase 2/3 study evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE disease)

Ahmet Ozen,Voranush Chongsrisawat,Asena Pinar Sefer,Burcu Kolukisa,Jessica J. Jalbert, Jutta L. Miller,Karoline A. Meagher, Taylor Brackin,Hagit Baris Feldman,Orly Eshach Adiv,Safa Baris,Elif Karakoc-Aydiner,Sevgi Bilgic Eltan, Melek Yorgun Altunbaş,Rabia Ergelen,Ivan J. Fuss, Heather Moorman, Mary Magliocco,Helen Matthews,Beatriz E. Marciano

Immunobiology（2023）

引用 1|浏览12
暂无评分
关键词
cd55 deficiency,pozelimab,angiopathic thrombosis,chaple disease,protein-losing
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要